Clinical Trial Update: GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating GLP-1 receptor agonists in patients with Polycystic Ovary Syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED